Search CORE

9 research outputs found

Anti-HER2 vaccines: new prospects for breast cancer therapy

Author: A Choudhury
A Concetti
A Dols
A Dols
A Mantovani
A Sica
AB Riemer
AK Nowak
AK Nowak
AL Coveler
André Pèlegrin
B Fisk
B Seliger
B Zhang
BF Johnson
BJ Czerniecki
BM Fendly
BW Anderson
C Bengala
CH Huber
CT Viehl
DH Munn
DJ Slamon
E Di Carlo
E Lekka
EA Mittendorf
EA Mittendorf
EA Mittendorf
EA Reits
EP Winer
F Burnet
F Herrmann
F Rilke
FS Hodi
FS Hodi
FS Hodi
G Curigliano
GE Peoples
GE Peoples
GE Peoples
H Cho
H Fakhrai
Isabelle Navarro-Teulon
J Jacob
J Jasinska
J Lustgarten
J Shimizu
J Stagg
JB Jacob
JB Jacob
JL Murray
JP Holmes
JS Ross
JT Garrett
JW Park
K Azuma
K Berns
K Mohanty
K Takeda
KL Knutson
KL Knutson
L Aurisicchio
LA Emens
LC Benavides
LH Butterfield
M Campbell
M Coelho
M Friberg
M Martín
M Pegram
M Rescigno
M Schmidt
MA Cobleigh
Maha Zohra Ladjemi
MD Pegram
MEC Lutsiak
MJ Ellis
MJ Smyth
ML Disis
ML Disis
ML Disis
ML Disis
ML Disis
ML Disis
ML Disis
ML Disis
MM Seavey
MP Piechocki
MT Hueman
N Alvarez-Rueda
NJ Nesslinger
NK Dakappagari
NK Dakappagari
NK Nanda
O Radkevich-Brown
P Brossart
P Gallo
P Kalinski
P Kaliński
P Kiewe
P Lollini
P Rovere
PI Schrier
PS Kim
R Baral
R Nahta
RA Lake
RL Pañares
S Kageyama
S Kitano
S Pal
S Rovero
S Sas
S Vertuani
S Wagner
SA Pilon
T Chan
Thierry Chardès
TJ Curiel
TZ Zaks
W Wei
William Jacot
WJ Slichenmyer
WZ Wei
Y Chen
Y Sakai
YL Yip
Z Chen
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Reply to M. Sun et al

Author: Dmitry A. Nosov
Motzer RJ
William J. Slichenmyer
Publication venue: 'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study

Serum Prostate-Specific Antigen Decline as a Marker of Clinical Outcome in Hormone-Refractory Prostate Cancer Patients: Association With Progression-Free Survival, Pain End Points, and Survival

Author: Alex McMillan
Eric J. Small
Liang Chen
Mario Eisenberger
Mark Meyer
Peter F. Lenehan
William J. Slichenmyer
Publication venue: 'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study

Phase Ib trial of the CpG-A Oligonucleotide CMP-001 combined with pembrolizumab (Pembro) in patients with advanced melanoma.

Author: Arthur M. Krieg
David J. Mauro
Hassane M. Zarour
Mohammed M. Milhem
Nashat Y. Gabrail
Norman M. Greenberg
William J. Slichenmyer
Publication venue: 'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study

Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydrocortisone

Author: Eric J. Small
Frederick J. Meyers
Leonard M. Reyno
Liang Chen
M. Ernest Marshall
Mario Eisenberger
Mark Meyer
Peter F. Lenehan
Ronald B. Natale
William J. Slichenmyer
Publication venue: 'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study

Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

Author: A. A. Anischenko
Alexei A. Lyulko
Andrew Strahs
Brooke Esteves
Cotreau MM
Dinesh C. Doval
Dmitry A. Nosov
Eskens FALM
Kaelin WG
Oleg N. Lipatov
Pankaj Bhargava
Raju T. Chacko
William J. Slichenmyer
Publication venue: 'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study

core

core